Cleanroom Maintenance Significantly Reduces Abundance but Not Diversity of Indoor Microbiomes by Alexander Mahnert (552332)

Image_3_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

Image_2_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

Image_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

Table_1_ACEI/ARB Medication During ICU Stay Decrease All-Cause In-hospital Mortality in Critically Ill Patients With Hypertension: A Retrospective Cohort Study Based on Machine Lea... by Boshen Yang (11935403)

Image2_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…<p>Introduction: We recently showed that a decellularized leaf scaffold can be loaded with polylactic-co-glycolic acid (PLGA)-based rapamycin nanoparticles, this leaf patch can then inhibit venous neointimal hyperplasia in a rat inferior vena cava (IVC) venoplasty model. …”

Image1_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

“…<p>Introduction: We recently showed that a decellularized leaf scaffold can be loaded with polylactic-co-glycolic acid (PLGA)-based rapamycin nanoparticles, this leaf patch can then inhibit venous neointimal hyperplasia in a rat inferior vena cava (IVC) venoplasty model. …”

Pioglitazone Decreases Hepatitis C Viral Load in Overweight, Treatment Naïve, Genotype 4 Infected-Patients: A Pilot Study by Mario Chojkier (82942)

“…</p> <h3>Conclusion/Significance</h3><p>This is the first documentation that Pioglitazone decreases the serum HCV RNA titers independently of PEG-Interferon-α2/ribavirin treatment. …”

ATP/EMTP model and data. by Basem Abd-Elhamed Rashad (17781467)

Subjects:

Case of normal load changing. by Basem Abd-Elhamed Rashad (17781467)

Subjects:

Presentation for different studied faults. by Basem Abd-Elhamed Rashad (17781467)

Subjects:

Src-induced tyrosine phosphorylation of Kv2.1 in CHO cells is significantly decreased in Kv2.1(S800A) mutants. by Kai He (157282)

DNA fragmentation detected by the TUNEL assay. by Fatema Calcuttawala (8399577)

Survivability is decreased in zebrafish embryos following exogenous treatment with an amino-terminal fragment of nApoE4_1-151. by Madyson M. McCarthy (9238322)

Cross-plots of (a) the proposed GPR, Ranjbar-Karaml et al. [14], Christaras et al. [52], Feng et al. [16], Gowida et al. [17] models and (b) Khandelwal et al. [13], Brandås et al.... by Fahd Saeed Alakbari (10701871)

Subjects:

Selected metabolic traits significantly associated with FFMI^a in a linear regression model adjusted for age and sex in the KORA S4 sample. by Carolin Jourdan (155791)

“…a<p>Fat Free Mass Index;</p>b<p>direction of the association (positive or negative);</p>c<p>for multiple testing adjusted p-value;</p>d<p>adjusted R² of the linear model;</p>e<p>p-gain, fold decrease in the p-value of association for the pair of metabolites, compared to the lowest of two p-values for the single metabolites;</p>f<p>confirmed in KORA F4, for * significance and direction; # confirmed for xLeu in F4, n.a., metabolite was not available in F4; AAs, amino acids; Σ aromatic amino acids, sum of tyrosine, phenylalanine, and tryptophan; Σ BCAAs, sum of valine, isoleucine, and leucine; Σ glucogenic amino acids, sum of alanine, glycine, and serine.…”

Demographic and clinical parameters. by Jesse D. de Groot (15401476)

Subjects:

List of IPA-determined "Disease or Cellular Functions" significantly dysregulated by ZIKV infection at 5 dpi. by Mahamud-ur Rashid (3275076)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16]. by Lisa Thiele (6468056)

Subjects: